Literature DB >> 3306670

Use of a synthetic peptide antigen to generate antisera reactive with a proteolytic processing site in native human proinsulin: demonstration of cleavage within clathrin-coated (pro)secretory vesicles.

D F Steiner, J Michael, R Houghten, M Mathieu, P R Gardner, M Ravazzola, L Orci.   

Abstract

Polyclonal antibodies reactive with a cleavage site in human proinsulin (HPI) (C-peptide-A-chain junction) have been raised (rabbit, guinea pig) using a synthetic peptide antigen coupled with keyhole limpet hemocyanin. These antisera recognize native HPI and des-31,32-HPI equally well but react 20-50 times less well with des-64,65-HPI, the intermediate cleaved at the C-peptide-A-chain junction and lacking the Lys-Arg pair. The guinea pig antisera did not recognize insulin but reacted weakly with C peptide at high concentrations; the rabbit antisera reacted with neither insulin nor C peptide. Immunocytochemical studies with human islet tissue localized the immunoreactivity of these antisera to clathrin-coated (pro)secretory vesicles derived from the trans Golgi, indicating that cleavage of the C-peptide-A-chain junction of proinsulin occurs mainly, if not exclusively, in this compartment of the beta cell.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3306670      PMCID: PMC299034          DOI: 10.1073/pnas.84.17.6184

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Ultrastructural localization of intracellular antigens by the use of protein A-gold complex.

Authors:  J Roth; M Bendayan; L Orci
Journal:  J Histochem Cytochem       Date:  1978-12       Impact factor: 2.479

2.  Specimen preparation for electron microscopy using low temperature embedding resins.

Authors:  B L Armbruster; E Carlemalm; R Chiovetti; R M Garavito; J A Hobot; E Kellenberger; W Villiger
Journal:  J Microsc       Date:  1982-04       Impact factor: 1.758

3.  Studies on the conversion of proinsulin to insulin. I. Conversion in vitro with trypsin and carboxypeptidase B.

Authors:  W Kemmler; J D Peterson; D F Steiner
Journal:  J Biol Chem       Date:  1971-11-25       Impact factor: 5.157

4.  A clathrin-coated, Golgi-related compartment of the insulin secreting cell accumulates proinsulin in the presence of monensin.

Authors:  L Orci; P Halban; M Amherdt; M Ravazzola; J D Vassalli; A Perrelet
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

Review 5.  Golgi/granule processing of peptide hormone and neuropeptide precursors: a minireview.

Authors:  D F Steiner; K Docherty; R Carroll
Journal:  J Cell Biochem       Date:  1984       Impact factor: 4.429

6.  The production and characterization of monoclonal antibodies specific for human proinsulin using a sensitive microdot assay procedure.

Authors:  O D Madsen; R M Cohen; F W Fitch; A H Rubenstein; D F Steiner
Journal:  Endocrinology       Date:  1983-12       Impact factor: 4.736

7.  Studies on the secretion of newly synthesized proinsulin and insulin from isolated rat islets of Langerhans.

Authors:  H Sando; J Borg; D F Steiner
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

8.  Human major histocompatibility complex class I antigens: residues 61-83 of the HLA-B7 heavy chain specify an alloreactive site.

Authors:  L E Walker; T A Ketler; R A Houghten; G Schulz; A Chersi; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

9.  Human proinsulin-specific antigenic determinants identified by monoclonal antibodies.

Authors:  O D Madsen; B H Frank; D F Steiner
Journal:  Diabetes       Date:  1984-10       Impact factor: 9.461

View more
  19 in total

1.  Kinetic analysis of the type-1 proinsulin endopeptidase by a monoclonal antibody-based immunoadsorbent assay.

Authors:  E M Bailyes; J C Hutton
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

Review 2.  How peptide hormone vesicles are transported to the secretion site for exocytosis.

Authors:  Joshua J Park; Y Peng Loh
Journal:  Mol Endocrinol       Date:  2008-07-31

Review 3.  Applications of immunogold and lectin-gold labeling in tumor research and diagnosis.

Authors:  J Roth; C Zuber; P Komminoth; T Sata; W P Li; P U Heitz
Journal:  Histochem Cell Biol       Date:  1996-07       Impact factor: 4.304

Review 4.  Sorting and storage during secretory granule biogenesis: looking backward and looking forward.

Authors:  P Arvan; D Castle
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

Review 5.  Sorting and processing of secretory proteins.

Authors:  P A Halban; J C Irminger
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

6.  A member of the eukaryotic subtilisin family (PC3) has the enzymic properties of the type 1 proinsulin-converting endopeptidase.

Authors:  E M Bailyes; K I Shennan; A J Seal; S P Smeekens; D F Steiner; J C Hutton; K Docherty
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

7.  Proinsulin endoproteolysis confers enhanced targeting of processed insulin to the regulated secretory pathway.

Authors:  R Kuliawat; D Prabakaran; P Arvan
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

8.  Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3.

Authors:  S P Smeekens; A G Montag; G Thomas; C Albiges-Rizo; R Carroll; M Benig; L A Phillips; S Martin; S Ohagi; P Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

9.  Tolerance induced by physiological levels of secreted proteins in transgenic mice expressing human insulin.

Authors:  P J Whiteley; J P Lake; R F Selden; J A Kapp
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

10.  Acute ablation of PERK results in ER dysfunctions followed by reduced insulin secretion and cell proliferation.

Authors:  Daorong Feng; Jianwen Wei; Sounak Gupta; Barbara C McGrath; Douglas R Cavener
Journal:  BMC Cell Biol       Date:  2009-09-04       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.